Global Infection Control Market 2020-2024 | Evolving Opportunities with 3M Co. and Astellas Pharma Inc. | Technavio

Technavio has announced its latest market research report titled global infection control market 2020-2024. (Graphic: Business Wire)

LONDON--()--The global infection control market is expected to grow by USD 29.49 billion during 2020-2024, progressing at a CAGR of over 4% during the forecast period. The growth of the market can be attributed to several factors such as the strong incidence of HAIs and the increasing number of surgical procedures worldwide. Furthermore, the growing geriatric population leads to a higher percentage of people susceptible to the risk of acquiring infection. All these factors are expected to drive the infection control market during the forecast period. Request a free sample report

Read the 155-page report with TOC on “Infection Control market research report by Type (Therapeutic and Non-therapeutic), Geography (Asia, Europe, North America, and ROW), and the Segment Forecasts, 2020-2024”.

https://www.technavio.com/report/infection-control-market-industry-analysis

Infection Control Market Type Outlook (Revenue, USD Million, 2020-2024)

  • Therapeutic
  • Non-therapeutic

Therapeutics were the largest segment in the market during 2019 due to their rising demand as anti-infectives used for the prevention and treatment of various diseases. These anti-infectives include antiparasitic drugs, antibiotics, anti-viral, and anti-fungal drugs. Increase in spending on infection control therapeutic regimen to avoid comorbidity associated with bacterial infections will drive the growth of this segment during the forecast period.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Infection Control Market Regional Outlook (Revenue, USD Million, 2020-2024)

  • Asia
  • Europe
  • North America
  • ROW

North America was the fastest growing geographic segment in 2019, followed by Europe, Asia, and ROW, respectively. This can be attributed to the increasing investments in R&D by large pharmaceutical companies. The region is anticipated to contribute the largest infection control market share due to the presence of a proper regulatory framework for the approval of new drugs. Furthermore, the presence of a huge patient pool and growing number of ambulatory surgery centers in the US is leading to an increase in demand for infection control interventions.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

Major Five Infection Control Companies:

3M Co.

3M Co. is headquartered in the US and operates the business under various segments such as Industrial, Safety and graphics, Health care, Electronics and energy, and Consumer. The company offers a broad range of sterilizers, including 3M Steri-Vac Sterilizer/Aerator 8XL. This sterilizer is used for the sterilization of heat and moisture-sensitive instruments and devices.

Astellas Pharma Inc.

Astellas Pharma Inc. is headquartered in Japan and offers products through the business unit: Pharmaceuticals. The company offers Sawacillin and Flemoclav Solutab drugs. The company launched SMYRAF tablets for the treatment of rheumatoid arthritis and Dafclir tablets 200 milligrams in Japan for the treatment of infectious enteritis.

Cantel Medical Corp.

Cantel Medical Corp. is headquartered in the US and operates under various business segments, namely Medical, Life sciences, Dental, and Dialysis. The company offers Dry Fog equipment and REVOX sterilization systems and services.

Ecolab Inc.

Ecolab Inc. is headquartered in the US and offers products through the following business segments: Global industrial, Global institutional, Global energy, and Other. The company offers a daily disinfectant cleaner, virucide, and deodorizer, namely OxyCide. It is designed for daily hospital use on both flexible and hard non-porous surfaces.

Getinge AB

Getinge AB is headquartered in Sweden and offers products through the following business segments: Acute care therapies, Life science, and Surgical workflows. The company offers a wide range of washer-disinfectors for high-throughput reprocessing.

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: https://www.technavio.com

Release Summary

The global infection control market is expected to grow by USD 29.49 billion during 2020-2024, progressing at a CAGR of over 4%.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: https://www.technavio.com